anastrozole has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 2 |
| An, Y | 1 |
| Ma, W | 1 |
| Yu, H | 1 |
| Lu, Y | 1 |
| Zhang, X | 1 |
| Liu, W | 1 |
| Wang, T | 1 |
| Xiao, R | 1 |
| Koleck, TA | 1 |
| Bender, CM | 1 |
| Sereika, SM | 1 |
| Ryan, CM | 1 |
| Ghotkar, P | 1 |
| Brufsky, AM | 1 |
| Jankowitz, RC | 1 |
| McAuliffe, PF | 1 |
| Clark, BZ | 1 |
| Conley, YP | 1 |
2 other studies available for anastrozole and Cognitive Decline
| Article | Year |
|---|---|
27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Avoidance Learning; Cognitive Dysfunction; Dysbiosis; Ga | 2020 |
Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cognit | 2017 |